Document
IPR2022-00853, No. 2028 Exhibit - World Intell Prop Org Patent Application No WO 02077029 A2 (P.T.A.B. Jul. 19, 2022)
Cite Document
IPR2022-00853, No. 2028 Exhibit - World Intell Prop Org Patent Application No WO 02077029 A2 (P.T.A.B. Jul. 19, 2022)
+ More Snippets
Document
IPR2022-00853, No. 2013 Exhibit - Renier Brentjens et al, Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells case report of an unforeseen adverse event in a...
Cite Document
IPR2022-00853, No. 2013 Exhibit - Renier Brentjens et al, Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells case report of an unforeseen adverse event in a phase I
+ More Snippets
Document
IPR2022-00853, No. 2020 Exhibit - James N Kochenderfer et al, B cell depletion and remissions of malignancy along with cytokine associated toxicity in a clinical trial of anti CD 19 chimeric antige...
Cite Document
IPR2022-00853, No. 2020 Exhibit - James N Kochenderfer et al, B cell depletion and remissions of malignancy along with cytokine associated toxicity in a clinical trial of anti CD 19 chimeric antigen r
+ More Snippets
Document
IPR2022-00853, No. 2011 Exhibit - Brian G Till et al, Adoptive immunotherapy for indolent non Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20 specific ...
Cite Document
IPR2022-00853, No. 2011 Exhibit - Brian G Till et al, Adoptive immunotherapy for indolent non Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20 specific T cells, 112
+ More Snippets
Document
IPR2022-00853, No. 2030 Exhibit - Amendments to the Claims Nov 13, 2018, US Patent Application No 15,353,899 (P.T.A.B. Jul. 19, 2022)
Cite Document
IPR2022-00853, No. 2030 Exhibit - Amendments to the Claims Nov 13, 2018, US Patent Application No 15,353,899 (P.T.A.B. Jul. 19, 2022)
+ More Snippets
Document
IPR2022-00853, No. 2004 Exhibit - Gina Kolata, A Cancer Treatment Makes Leukemia Vanish, but Creates More Mysteries, NY TIMES Feb 2, 2022, httpswwwnytimescom20220202healthleukem...
Cite Document
IPR2022-00853, No. 2004 Exhibit - Gina Kolata, A Cancer Treatment Makes Leukemia Vanish, but Creates More Mysteries, NY TIMES Feb 2, 2022, httpswwwnytimescom20220202healthleukemia car t immunotherapyh
+ More Snippets
Document
IPR2022-00853, No. 2045 Exhibit - SITC Smalley Award 2013 Recipient, SOC���Y FOR IMMUNOTHERAPY OF CANCER, httpswwwsitcancerorgfundingnamed funds and awards2smalley2013 las...
Cite Document
IPR2022-00853, No. 2045 Exhibit - SITC Smalley Award 2013 Recipient, SOC���Y FOR IMMUNOTHERAPY OF CANCER, httpswwwsitcancerorgfundingnamed funds and awards2smalley2013 last visited July 19, 2022 (P.T.
+ More Snippets
Document
IPR2022-00853, No. 2036 Exhibit - Latest paper from the father of CAR T CAR T really completely cured cancer, MEDICALTRENDORG, httpsmedicaltrendorg20220203latest paper from the fathe...
Cite Document
IPR2022-00853, No. 2036 Exhibit - Latest paper from the father of CAR T CAR T really completely cured cancer, MEDICALTRENDORG, httpsmedicaltrendorg20220203latest paper from the father of car t car t r
+ More Snippets
Document
IPR2022-00853, No. 2041 Exhibit - Renier J Brentjens et al, Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts, 13 CLINICAL CANCER RSCH 5426 2007...
Cite Document
IPR2022-00853, No. 2041 Exhibit - Renier J Brentjens et al, Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts, 13 CLINICAL CANCER RSCH 5426 2007 (P.T.A.B. Jul. 19
+ More Snippets
Document
IPR2022-00853, No. 2006 Exhibit - Denise Grady, FDA Approves First Gene Altering Leukemia Treatment, Costing $475,000, NY TIMES Aug 30, 2017, httpswwwnytimescom20170830healthgen...
Cite Document
IPR2022-00853, No. 2006 Exhibit - Denise Grady, FDA Approves First Gene Altering Leukemia Treatment, Costing $475,000, NY TIMES Aug 30, 2017, httpswwwnytimescom20170830healthgene therapy cancerhtml (P
+ More Snippets
Document
IPR2022-00853, No. 2005 Exhibit - Denise Grady, In Girl���s Last Hope, Altered Immune Cells Beat Leukemia, NY TIMES Dec 9, 2012, httpswwwnytimescom20121210healtha breakthrough again...
Cite Document
IPR2022-00853, No. 2005 Exhibit - Denise Grady, In Girl���s Last Hope, Altered Immune Cells Beat Leukemia, NY TIMES Dec 9, 2012, httpswwwnytimescom20121210healtha breakthrough against leukemia using a
+ More Snippets
Document
IPR2022-00853, No. 2022 Exhibit - Holly Auer, Penn Medicine Immunotherapy Pioneer Carl June, MD, Awarded 2015 Paul Ehrlich and Ludwig Darmstaedter Prize, PENN TODAY Mar 11, 2015 (P...
Cite Document
IPR2022-00853, No. 2022 Exhibit - Holly Auer, Penn Medicine Immunotherapy Pioneer Carl June, MD, Awarded 2015 Paul Ehrlich and Ludwig Darmstaedter Prize, PENN TODAY Mar 11, 2015 (P.T.A.B. Jul. 19, 202
+ More Snippets
Document
IPR2022-00853, No. 2037 Exhibit - Bipulendu Jena et al, Redirecting T cell specificity by introducing a tumor specific chimeric antigen receptor, 116 BLOOD 1035 2010 (P.T.A.B. Jul. 19, 2022)
Cite Document
IPR2022-00853, No. 2037 Exhibit - Bipulendu Jena et al, Redirecting T cell specificity by introducing a tumor specific chimeric antigen receptor, 116 BLOOD 1035 2010 (P.T.A.B. Jul. 19, 2022)
+ More Snippets
Document
IPR2022-00853, No. 2010 Exhibit - Barbara Savoldo et al, CD28 costimulation improves expansion and persistence of chimeric antigen receptor modified T cells in lymphoma patients, 121 J CLIN...
Cite Document
IPR2022-00853, No. 2010 Exhibit - Barbara Savoldo et al, CD28 costimulation improves expansion and persistence of chimeric antigen receptor modified T cells in lymphoma patients, 121 J CLINICAL INVEST
+ More Snippets
Document
IPR2022-00853, No. 2015 Exhibit - Jennifer Couzin Frankel, The dizzying journey to a new cancer arsenal, 340 SCI 1514 2013 (P.T.A.B. Jul. 19, 2022)
Cite Document
IPR2022-00853, No. 2015 Exhibit - Jennifer Couzin Frankel, The dizzying journey to a new cancer arsenal, 340 SCI 1514 2013 (P.T.A.B. Jul. 19, 2022)
+ More Snippets